Whereas AFP levels reflect intrahepatic tumour burden, PIVKA-II levels reflect tumour behaviour such as vascular invasion and extrahepatic disease (Park & Park, 2013; Ji et al., 2016; Kang et al., 2012). This evidence concerns the gene AFP and neoplasm.